As already mentioned, the most significant efforts to develop peptide-based vaccines for AD and other neurodegenerative diseases have focussed on targeting specific epitopes of Aβ, tau, and α-syn (Section 3.2, Section 3.3, and Section 3.4, respectively). The gene discussed is MAPT; the disease is neurodegenerative disease.